New Study Finds CER May Help Lower Costs of Specialty Pharmaceuticals

Specialty pharmaceuticals are complex to manufacture and distribute, often difficult to administer, may require special patient monitoring and are a rapidly growing share of the costs to health plans. But for some patients, these pharmaceuticals hold promise for treating many serious diseases. A new Health Affairs brief outlines the key challenges around their use.